Focusing on inflammation in the treatment of atherosclerosis

Area of Science:

• Cardiovascular Medicine
• Inflammation Research
• Medical Therapeutics

Background:

• Atherosclerosis treatment traditionally targets epidemiological risk factors.
• Recent research highlights inflammation's critical role in atherosclerosis pathophysiology.
• Understanding inflammation's role necessitates evaluating current therapies' impact.

Purpose of the Study:

• To review the role of inflammation in atherosclerosis.
• To explore how modern therapies influence atherosclerotic inflammation.
• To bridge the gap between epidemiological and pathophysiological approaches in treatment.

Main Methods:

• Literature review of atherosclerosis pathophysiology.
• Analysis of inflammatory mechanisms in atherosclerosis.
• Evaluation of modern therapeutic interventions and their anti-inflammatory effects.

Main Results:

• Inflammation is a key driver in the development and progression of atherosclerosis.
• Current therapies, while targeting risk factors, may also modulate inflammatory pathways.
• Further research is needed to fully elucidate and leverage these anti-inflammatory effects.

Conclusions:

• Inflammation is central to atherosclerosis, shifting focus from risk factors alone.
• Modern therapies possess the potential to modify atherosclerotic inflammation.
• Integrating pathophysiological insights into treatment strategies is crucial for improved outcomes.